Expertise in
4
conditions

Won-jang M. Kim

Songnam, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Songnam, KR 

Overview

Won-jang Kim practices practicing medicine in Songnam, Republic of Korea.

Kim is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Unstable Angina, Angina, Percutaneous Coronary Intervention (PCI), and Angioplasty.

They are actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 12 clinical trials.

Locations

Songnam, Republic of Korea
Other Locations
Goyang, Republic of Korea
Republic of Korea
Gyeonggi-do, Republic of Korea
Yeouido St. Mary's Hospital, St. Vincent's Hospital, Suwon, Republic of Korea
Seoul, 138736, Republic of Korea
Gwangju, 501757, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Recruiting
Publish Date: January 02, 2026
Intervention Type: Procedure
A Multicenter, Prospective Cohort to Evaluate the Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
A Multicenter, Prospective Cohort to Evaluate the Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions
Enrollment Status: Terminated
Publish Date: April 15, 2026
Intervention Type: Other
Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Device
Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: September 30, 2025
Intervention Type: Device
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: June 06, 2025
Intervention Type: Drug
Study Drugs: Tailored antithrombotic strategy, Conventional antithrombotic strategy
Study Phase: Phase 4
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Drug
Study Phase: Phase 4
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: December 20, 2023
Intervention Type: Device
Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2023
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device, Drug
Study Drug: Optimal Medical treatment
Study Phase: Phase 4
A Prospective, Open Label, Multi-center, Dual Arm, Randomized Trial : The ROTA-ISR (Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis) Trial
A Prospective, Open Label, Multi-center, Dual Arm, Randomized Trial : The ROTA-ISR (Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis) Trial
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
View 9 Less Clinical Trials

83 Total Publications

Role of routine surveillance stress testing in patients with or without imaging-guided or physiology-guided PCI.
Role of routine surveillance stress testing in patients with or without imaging-guided or physiology-guided PCI.
Journal: Heart (British Cardiac Society)
Published: May 15, 2025

Frequently Asked Questions about Won-jang M. Kim

Is Won-jang M. Kim a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Won-jang M. Kim is classified as an Advanced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Won-jang M. Kim participate in research or clinical trials?

Yes. Won-jang M. Kim has published 83 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Won-jang M. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kim's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile